Do Traders Think Syros Pharmaceuticals Inc (SYRS) Can Keep Climbing Wednesday?

The market has been neutral on Syros Pharmaceuticals Inc (SYRS) stock recently. SYRS gets a Neutral score from InvestorsObserver Stock Sentiment Indicator.

Syros Pharmaceuticals Inc has a Neutral sentiment reading. Find out what this means for you and get the rest of the rankings on SYRS!

See Full SYRS Report

What is Stock Sentiment?

Sentiment uses short term technical analysis to gauge whether a stock is desired by investors. As a technical indicator, it focuses on recent trends as opposed to the long term health of the underlying company. Updates for the company such as a earnings release can move the stock away from current trends. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With SYRS Stock Today?

Syros Pharmaceuticals Inc (SYRS) stock is down -4.02% while the S&P 500 has gained 0.29% as of 9:56 AM on Wednesday, Nov 1. SYRS is down -$0.10 from the previous closing price of $2.49 on volume of 111,052 shares. Over the past year the S&P 500 has gained 8.62% while SYRS is down -52.39%. SYRS lost -$0.26 per share in the over the last 12 months. To screen for more stocks like Syros Pharmaceuticals Inc click here.

More About Syros Pharmaceuticals Inc

Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in a non-coding regulatory region of the genome controlling the activation and repression of genes. It is primarily involved in the segments of the pharmaceutical, biotechnology, and other related markets that address gene control and cancer. The Company operates only in the United States. Click Here to get the full Stock Report for Syros Pharmaceuticals Inc stock.